Peptide mimotopes of rabies virus glycoprotein with immunogenic activity (Q33466606)

27 July 2017

title

Peptide mimotopes of rabies virus glycoprotein with immunogenic activity (English)

1 reference

27 July 2017

0 references

rabies virus

1 reference

Koussay Dellagi

1 reference

27 July 2017

Mehdi Houimel

1 reference

27 July 2017

language of work or name

English

0 references

publication date

9 June 2009

1 reference

27 July 2017

1 reference

27 July 2017

1 reference

27 July 2017

1 reference

27 July 2017

page(s)

4648-4655

1 reference

From rabies to rabies-related viruses

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Lyssaviruses: current trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Genomic diversity and evolution of the lyssaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Walking along the rabies genome: is the large G-L intergenic region a remnant gene?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Rabies virus glycoprotein is a trimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Differential stability and fusion activity of Lyssavirus glycoprotein trimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Mechanisms of Rabies Virus Neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Antigenic variants of CVS rabies virus with altered glycosylation sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Identification of a conserved linear epitope at the N terminus of the rabies virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Human rabies immunoglobulin assayed by the rapid fluorescent focus inhibition test suppresses active rabies immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Searching for Peptide Ligands with an Epitope Library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

A priori delineation of a peptide which mimics a discontinuous antigenic determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Epitope mapping: the first step in developing epitope-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

The molecular biology of rabies viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.055

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.05.055

1 reference

27 July 2017

1 reference